Scarica l'app Stockscreener
5.365
7.30%
0.365
Dopo l'orario di chiusura:
5.02
-0.345
-6.43%
Precedente Chiudi:
$5.00
Aprire:
$5.12
Volume 24 ore:
2.17M
Relative Volume:
0.81
Capitalizzazione di mercato:
$799.68M
Reddito:
-
Utile/perdita netta:
$-207.02M
Rapporto P/E:
-3.8106
EPS:
-1.4079
Flusso di cassa netto:
$-176.59M
1 W Prestazione:
-1.01%
1M Prestazione:
+5.40%
6M Prestazione:
+92.29%
1 anno Prestazione:
+117.21%
Intervallo 1D:
$5.09
$5.52
Intervallo di 1 settimana:
$4.95
$5.62
Portata 52W:
$1.285
$7.18
Annexon Inc Stock (ANNX) Company Profile
Nome
Annexon Inc
Settore
Industria
Telefono
(650) 822-5500
Indirizzo
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.365 | 745.28M | 0 | -207.02M | -176.59M | -1.4079 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-23 | Iniziato | Chardan Capital Markets | Buy |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-10-30 | Iniziato | Wells Fargo | Overweight |
| 2023-05-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-09-16 | Iniziato | Jefferies | Buy |
| 2022-09-09 | Iniziato | BTIG Research | Buy |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-09-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-26 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | BofA Securities | Buy |
| 2020-08-18 | Iniziato | Cowen | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Annexon Inc Borsa (ANNX) Ultime notizie
Annexon (NASDAQ:ANNX) Trading Up 10.2%What's Next? - MarketBeat
Are Healthcare Stocks Falling Behind American Well (AMWL) in Performance This Year? - Bitget
Are Medical Stocks Lagging American Well (AMWL) This Year? - Yahoo Finance
If You Invested $1,000 in Annexon, Inc. (ANNX) - Stock Titan
ANNX PE Ratio & Valuation, Is ANNX Overvalued - Intellectia AI
Annexon, Inc. (ANNX) Discusses Vision Preservation in Geographic Atrophy With C1q Inhibition and Key Insights From ARCHER TrialsSlideshow (NASDAQ:ANNX) 2026-03-20 - Seeking Alpha
Chardan Capital Maintains Buy Rating on Annexon (ANNX) with $16 - GuruFocus
Annexon's (ANNX) "Buy" Rating Reaffirmed at Chardan Capital - MarketBeat
H.C. Wainwright reiterates Buy on Annexon stock, $14 target By Investing.com - Investing.com Canada
Annexon Inc to Host KOL Event Transcript - GuruFocus
ANNX Earnings History & Surprises | EPS & Revenue Results | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4 - MarketBeat
ANNX: Phase III trial for C1q inhibition in GA is fully enrolled, with results expected in Q4 - TradingView
ANNX: Phase III trial for C1q inhibition in GA targets vision preservation with robust clinical design - TradingView
Portfolio Update: Will Annexon Inc benefit from government policyWeekly Stock Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Annexon reports inducement grant to new employee under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ANNX SEC FilingsAnnexon, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Wall Street Recap: Is Annexon Inc in a bullish channel2026 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn
Insider Buying: William Carson Acquires 8,000 Shares of Annexon Inc (ANNX) - GuruFocus
William Carson Acquires 8,000 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan
Annexon (NASDAQ:ANNX) Stock Price Down 8.1%Should You Sell? - MarketBeat
Annexon (NASDAQ:ANNX) Shares Up 6.8%Time to Buy? - MarketBeat
Rhenman & Partners Asset Management AB Boosts Holdings in Annexon, Inc. $ANNX - MarketBeat
Annexon (ANNX) CFO Lew sells shares to cover RSU tax withholding - Stock Titan
Annexon, Inc. (ANNX) CMO sells shares to cover tax obligations - Stock Titan
Annexon (ANNX) EVP Overdorf sells shares to cover RSU tax - Stock Titan
Annexon (ANNX) EVP sells 5,566 shares to cover RSU tax withholding - Stock Titan
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference - MarketBeat
ANNX: Late-stage neuroinflammatory programs near key data and filings, with strong commercial focus - TradingView
Director files sale notice for 5,566 ANNX shares (NASDAQ: ANNX) - Stock Titan
ANNX (NASDAQ: ANNX) Rule 144 notice shows 5,894 shares to be sold; prior 5,290 sold - Stock Titan
ANNX (NASDAQ) Rule 144: Insider sale of 6,225 shares; 4,339 vested - Stock Titan
ANNX (NASDAQ: ANNX) Form 144 lists 5,565-share notice and recent insider sale - Stock Titan
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
ANNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Annexon Showcases Promising Drug Ahead of Pivotal Trial Data - StocksToTrade
Annexon Showcases Emerging Treatment with Topline Data on Horizon - timothysykes.com
ANNX Technical Analysis & Stock Price Forecast - Intellectia AI
Annexon Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Does Annexon Inc. meet Warren Buffett’s criteriaEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru
ANNX (NASDAQ: ANNX) insider sale notice: 5,820 shares tied to vesting - Stock Titan
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Annexon (ANNX) CFO receives 250,000 options and 62,500 RSUs in equity grant - Stock Titan
Annexon (ANNX) grants CMO 225,000 options and 56,250 RSUs - Stock Titan
Jamie Dananberg Sells 5,290 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
Insider Selling: Annexon (NASDAQ:ANNX) EVP Sells 5,290 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock - MarketBeat
Annexon (NASDAQ:ANNX) CFO Sells $40,118.61 in Stock - MarketBeat
Annexon (ANNX) EVP sells 7,857 shares to cover RSU tax withholding - Stock Titan
Annexon Inc Azioni (ANNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):